John J. Crowley

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Program in Biostatistics
Member
University of Washington
School of Public Health and Community Medicine
Biostatistics
Professor

Mailing Address

Southwest Oncology Group Statistical Center
Fred Hutchinson Cancer Research Center MP-557
1100 Fairview Ave N, PO Box 19024
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-4623
Fax: (206) 667-4408
johnc@swog.fhcrc.org
http://www.fhcrc.org/`scirep/PHS/CROWLEY.htm

Qualifications

Ph.D., University of Washington, 1973.
M.S., 1970.

Expertise and Research Interests

Design And Analysis Of Cancer Clinical Trials.

The Southwest Oncology Group (SWOG) is a national consortium of institutions and investigators whose mission is to make progress in the prevention and cure of cancer through clinical research. The Statistical Center, located in the Division of Public Health Sciences of the FHCRC, contributes to this mission through study design, protocol development, data management and quality control, data analysis, and statistical research.

SWOG has over 100 trialsopen for patient accrual in all sites of cancer, plus a large prostate cancer prevention trial. Recent advances have been made in the treatment of ovarian, bladder, prostate, lung, colon, and head and neck cancers. The Statistical Center's efforts are carried out by a staff of over 65 people, including eight faculty biostatisticians and a behavioral scientist.

My own emphasis within SWOG is in lung cancer and multiple myeloma. In addition to the design and analysis of trials in these disease sites,including a randomized study of high dose therapy and autologous transplantation in myeloma, I have been involved in assessing the importance of various laboratory findings in predicting survival and forming prognostic groups. My longstanding interest in developing exploratory tools for survival data has found fruitful application in these areas. My other current interest is in the education of cancer clinicians in the principles and pitfalls of cancer clinical trials.

Keywords

COS Keywords:

Cancer Or Carcinogenesis, Clinical Trial.

Additional Terms:

Cancer Clinical Trials, Survival Analysis.

Publications

  • Mick R, Crowley J, Cassady RJ, Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint, Control Clin Trials, 21(4), 343-359, 2000
  • Gooley TA, Leisenring W, Crowley J, et al, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, Stat Med, 18, 695-706, 1999
  • LeBlanc M, Crowley J, Using the bootstrap for estimation in group sequential design: An application to a clinical trial for nasopharyngeal cancer, Stat Med, 18, 2635-2644, 1999
  • Green S, Benedetti J, Crowley J, Clinical Trials in Oncology, 1997
  • Crowley J, LeBlanc M, Jacobson J, Salmon S, Some exploratory tools for survival analysis, Lecture Notes in Statistics. Proceedings of the first Seattle symposium in biostatistics; survival analysis, Seattle, Washington, 199-229, 1997

Profile Details

Last Updated: 3/8/2001

COS Expertise ID #373794
Reference this profile directly: http://myprofile.cos.com/crowleyj94